Yu Yong 4

What Happened

• Yu Yong, Chief Scientific Officer of GENELUX Corp (GNLX), was granted 119,318 restricted stock units (RSUs) on June 16, 2026. The Form 4 reports an acquisition price of $0 because these are compensation awards that convert to shares only upon vesting. This transaction is an award (not a purchase or sale).

Key Details

• Transaction date: 2026-06-16; Form 4 filed 2026-06-18 (timely filing).
• Transaction type/code: A — Grant/Award of RSUs.
• Shares involved: 119,318 RSUs; reported acquisition price: $0.
• Vesting/footnote: Per footnote F1, RSUs vest 25% on the first anniversary of the grant, then the remainder vests in 12 equal quarterly installments thereafter.
• Shares owned after transaction: not specified in the provided filing details.
• No 10b5-1 plan, tax-withholding sale, or immediate cash exercise reported.

Context

• RSUs are a form of equity compensation that convert to common stock only after vesting; they do not represent immediate stock purchases or sales. Grants are common for executive pay and do not necessarily signal a buy/sell view by the insider.